| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |